Long-form essays examining the scientific claims and limits of biological research, especially organoids in drug discovery, disease modeling, and Alzheimer's research. Readers get critical, detailed analysis of where lab models succeed, fail, and get overhyped, plus updates from the author's work on AI and health.

Official blog of the Open Targets platform, covering data releases, new genomic datasets and the research behind them. Readers get detailed release notes and behind-the-scenes stories on target identification for drug discovery.

A personal-essay-driven newsletter on data, companies and ideas at the frontier of biology, covering topics like AI in drug discovery, the economics of pharma R&D and founder stories. Readers get long-form analysis of the biotech landscape, investments and historical context of life sciences.

A weekly newsletter tracking AI and computational drug discovery, covering deals, startups, funding rounds and research papers in biopharma. Each issue pairs a main analytical essay with a roundup of recent industry news.